ONCOCYTE CORP (OCX) Stock Price, Quote, News and Overview

What is the stock price of ONCOCYTE CORP today?

The current stock price of OCX is 3.1 USD. The price increased by 0.65% in the last trading session.

What is the ticker symbol for ONCOCYTE CORP stock?

The exchange symbol of ONCOCYTE CORP is OCX and it is listed on the Nasdaq exchange.

On which exchange is OCX stock listed?

OCX stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for ONCOCYTE CORP stock?

8 analysts have analysed OCX and the average price target is 4.51 USD. This implies a price increase of 45.32% is expected in the next year compared to the current price of 3.1. Check the ONCOCYTE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is ONCOCYTE CORP worth?

ONCOCYTE CORP (OCX) has a market capitalization of 88.66M USD. This makes OCX a Micro Cap stock.

How many employees does ONCOCYTE CORP have?

ONCOCYTE CORP (OCX) currently has 45 employees.

What are the support and resistance levels for ONCOCYTE CORP (OCX) stock?

ONCOCYTE CORP (OCX) has a support level at 2.87 and a resistance level at 3.35. Check the full technical report for a detailed analysis of OCX support and resistance levels.

Is ONCOCYTE CORP (OCX) expected to grow?

The Revenue of ONCOCYTE CORP (OCX) is expected to grow by 104.75% in the next year. Check the estimates tab for more information on the OCX EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy ONCOCYTE CORP (OCX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of OCX, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of OCX, evaluating the profitability, health, valuation and growth aspects
• ONCOCYTE CORP (OCX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• ONCOCYTE CORP (OCX) Sales and EPS estimates to see what analysts future expectations are.
• ONCOCYTE CORP (OCX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• ONCOCYTE CORP (OCX) Insider and Institutional Ownership to learn about the owners and their transactions.
• ONCOCYTE CORP (OCX) Stock Chart to make your own analysis
• ONCOCYTE CORP (OCX) Latest news and press-releases to stay up to date.

Does ONCOCYTE CORP (OCX) stock pay dividends?

OCX does not pay a dividend.

When does ONCOCYTE CORP (OCX) report earnings?

ONCOCYTE CORP (OCX) will report earnings on 2025-05-13, before the market open.

What is the Price/Earnings (PE) ratio of ONCOCYTE CORP (OCX)?

ONCOCYTE CORP (OCX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.4).

What is the Short Interest ratio of ONCOCYTE CORP (OCX) stock?

The outstanding short interest for ONCOCYTE CORP (OCX) is 1.81% of its float. Check the ownership tab for more information on the OCX short interest.

ChartMill assigns a fundamental rating of 2 / 10 to OCX. OCX may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months OCX reported a non-GAAP Earnings per Share(EPS) of -4.4. The EPS decreased by -22.22% compared to the year before.

ChartMill assigns a Buy % Consensus number of 75% to OCX. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 75.47% and a revenue growth 104.75% for OCX